Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

Background: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. We investigated the cost-effectiveness of Xpert in...

Full description

Bibliographic Details
Main Authors: Prof Anna Vassall, PhD, Mariana Siapka, MSc, Nicola Foster, MSc, Lucy Cunnama, MSc, Lebogang Ramma, MSc, Prof Katherine Fielding, PhD, Kerrigan McCarthy, MSc, Prof Gavin Churchyard, PhD, Prof Alison Grant, PhD, Edina Sinanovic, PhD
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X1730205X

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X1730205X

Similar Items